About Guizhou Bailing Group Pharmaceutical Company

The company is a listed pharmaceutical company that integrates R&D, production and sales of medicinal drugs. It has a registered capital of 1,4112 million yuan, total assets of 7.059 billion yuan, and 6124 employees. In June 2010, the company was successfully listed on the Shenzhen Stock Exchange (stock code: SZ002424). The company is a listed pharmaceutical company integrating R&D, production and sales of medicinal products. The main products are the exclusive medicine product Yindan Heart and Brain Softgels, Cough Stop Syrup and Capsules, and the non-drug product Golden Sense capsules, Vitamin C silver tablets, children's Chai Gui antipyretic tablets, etc. Corporate honors: It has won honors such as “National Intellectual Property Advantage Enterprise”, “National Certified Enterprise Technology Center”, “National Contract-abiding and Trustworthy Enterprise”, “National Model Collective for National Unity and Progress”, the fourth batch of “Green Factories” from the Ministry of Industry and Information Technology, “Leading Enterprises in Agricultural Industrialization”, and Guizhou's first “Governor's Quality Award”. It has been selected for many years on the list of China's top 100 pharmaceutical industry companies and Guizhou enterprises “Top 100”.